SCHEMBL16330693

SCHEMBL16330693

CNC(C(=O)Nc1ncnc2c1c(C#N)cn2[C@@H]1O[C@H](CO)C(O)[C@@H]1OC)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.53
▸ PAX8 Q06710 1/20 0.53
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ADK P55263 7/20 0.43
▸ TMEM97 Q5BJF2 3/20 0.41
▸ SIGMAR1 Q99720 2/20 0.41
▸ ADORA3 P0DMS8 1/20 0.40
▸ DOT1L Q8TEK3 3/20 0.39
▸ PRMT5 O14744 1/20 0.39
▸ PRMT3 O60678 1/20 0.39
▸ DNMT1 P26358 1/20 0.39
▸ EHMT2 Q96KQ7 1/20 0.39
▸ OPRK1 P41145 1/20 0.38
▸ HTR2B P41595 1/20 0.38
▸ TP53 P04637 1/20 0.37
▸ STAT6 P42226 1/20 0.37
▸ HSPA8 P11142 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16330763 0.93 HIF1A (0.51) HIF1APAX8MEN1KMT2AADK
SCHEMBL16330723 0.91 HIF1A (0.63) HIF1APAX8ADKTMEM97SIGMAR1
SCHEMBL16330754 0.89 HIF1A (0.51) HIF1APAX8MEN1KMT2AADK
SCHEMBL16330760 0.88 HIF1A (0.49) HIF1APAX8ADKTMEM97SIGMAR1
SCHEMBL16330686 0.88 HIF1A (0.47) HIF1APAX8MEN1KMT2AADK
SCHEMBL16330724 0.84 HIF1A (0.60) HIF1APAX8ADKTMEM97SIGMAR1
SCHEMBL16330765 0.84 HIF1A (0.54) HIF1APAX8MEN1KMT2AADK
SCHEMBL16330722 0.83 HIF1A (0.65) HIF1APAX8ADKTMEM97SIGMAR1
SCHEMBL16330701 0.82 ADK (0.46) HIF1APAX8ADKPRMT5
SCHEMBL16330757 0.81 HIF1A (0.53) HIF1APAX8MEN1KMT2AADK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS ENZON PHARMACEUTICALS, INC. (US) 2013-01-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018010-A1 POLYMERIC CONJUGATES OF ADENINE NUCLEOSIDE ANALOGS VEGFA, MKI67, PCNA HIF1A 922/4885PAX8 3693/4885MEN1 2018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback